News

Wright Medical launch BIOTAPE XM(TM) Reinforcement Matrix

Tennessee, USA
Sep 16, 2008

Wright Medical Group, Inc. has announced the launch of BIOTAPE XM™ Reinforcement Matrix, a sterile, acellular xenograft matrix for reinforcement of soft-tissue repairs in foot and ankle surgical procedures.

BIOTAPE XM™ Reinforcement Matrix is the latest addition to Wright’s biologics portfolio of technologies for foot & ankle surgery.

Commenting on this, Eric E. Gay, Wright’s Director of Biologics Marketing, stated “The launch of BIOTAPE XM™ Reinforcement Matrix will help to expand our leadership position in the foot and ankle soft-tissue reinforcement market. In addition, BIOTAPE XM™ Matrix, being a material of animal origin, will provide a less burdensome entrance into many of our  international markets where human tissue regulations make providing human tissue products difficult and in some cases impossible.”